← Open Payments lookup

DAVID MCLAIN: Open Payments

NPI 1689614737 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$222,386 in 212 payments from 21 companies in 2025. Trend: 2023 $78,752 · 2024 $186,852 · 2025 $222,386

Grant: $217,128Food & beverage: $5,108Education: $150
CompanyPaymentsAmount
ABBVIE INC.47$217,890
Amgen Inc.44$957
Novartis Pharmaceuticals Corporation20$666
Mallinckrodt Hospital Products Inc.13$488
GlaxoSmithKline, LLC.13$392
UCB, Inc.18$312
PFIZER INC.15$276
AstraZeneca Pharmaceuticals LP9$276
Aurinia Pharma U.S., Inc.2$259
GENZYME CORPORATION7$239

Products named: RINVOQ, COSENTYX, ACTHAR, Bimzelx, SAPHNELO, TAVNEOS, LUPKYNIS, OTEZLA.

Industry payments across AL — which companies pay providers there.